NEW APPROACHES TO THE TREATMENT OF TYPE 1 AND TYPE 2 DIABETES MELLITUS: A 2025 PERSPECTIVE
Keywords:
diabetes mellitus, prevention, T1DM, T2DM, insulin, glucose, cell, cardiovascular, clinical.Abstract
This article discusses current treatment methods, preventive measures, innovations, and the 2025 outlook for type 1 and type 2 diabetes mellitus (T1DM and T2DM). It highlights the primary factors contributing to diabetes, as well as the major preventive strategies necessary to understand and reduce the risks of life-threatening complications.
References
1. Ministry of Health of the Republic of Uzbekistan. (n. Reforms in the field of medicine and digital health projects. https://www.minzdrav.uz
2. United Nations in Uzbekistan. Health sector reform. https://uzbekistan.un.org
3. World Health Organization. Universal health coverage. https://www.who.int
4. STT SSV. Programs for promoting a healthy lifestyle. https://www.ssv.uz
5. Zhaloliddinov, Sh. I. (2025, June 11). Postoperative complications: Risks and prevention of gastric ulcers (pp. 144–146).
6. Jaloliddinov, Sh. I. (2025, May 28). Perforated ulcer of the stomach and duodenum: Clinical, diagnostic, and surgical aspects (pp. 601–603).
7. Sherzod, J. (2024). Gastritis (pp. 38–40). World of Science.
8. Panagiotou, M., Strømmen, K., Brigato, L., de Galan, B. E., & Mougiakakou, S. (2025). Role of artificial intelligence in enhancing insulin recommendations and therapy outcomes. Die Diabetologie, 21(9), 695–703. https://doi.org/10.1007/s11428-025-01332-y
9. Symeonidis, P., Rizos, E., Andras, C., et al. (2025). Deep reinforcement learning for personalized insulin dosing and glucose control of hospitalized ICU patients. International Journal of Data Science and Analytics, 20, 6841–6854. https://doi.org/10.1007/s41060-025-00857-1
10. Zhang, H., Zhou, X. D., Shapiro, M. D., et al. (2025). Cardiovascular and renal outcomes of dual-combination therapies with GLP-1 receptor agonists and SGLT2 inhibitors: A systematic review and meta-analysis. Cardiovascular Diabetology, 24, Article 370. https://doi.org/10.1186/s12933-025-02900-8
11. Arow, Z., Hornik-Lurie, T., Hilu, R., et al. (2025). SGLT2 inhibitors and GLP-1 receptor agonists: Impact on mortality in diabetic patients with cardiovascular disease. Cardiovascular Diabetology, 24, Article 353. https://doi.org/10.1186/s12933-025-02874-7
